6 employees
Differentiated Therapeutics is to design and develop disease-modifying TPD therapies for patients with unmet medical need.
2021
$5M
from 1 investors over 1 rounds
Differentiated Therapeutics raised $5M on August 1, 2022
Investors: Curie.Bio